INSIDER
/
TRADES
Dashboard
Leaderboard
Congress
Watchlist
API
Pricing
Docs
Sign in
Get started
Elfont Robert Myles
Insider CIK 1648886 ·
AIMT
Chief Medical Officer
Track record
PRO
XXXX
$█.██M
██
+██%
XXXX
$█.██M
██
+██%
XXXX
$█.██M
██
+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/year
Already Pro? Log in
Trades across companies
Ticker
Code
Trade
Filed
Shares
Price
Value
Owned after
AIMT
Aimmune Therapeutics, Inc.
A Award
deriv
2016-02-26
2016-02-26
80,000
—
$0
80,000
SEC↗